Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine protease 21 (PRSS21, also known as testisin) is a cell-surface anchored serine protease and a member of the trypsin family of serine endopeptidases[3][4]. The protein catalyzes the hydrolysis of peptide bonds, preferentially at lysine or arginine residues, using a characteristic catalytic triad (His, Asp, Ser)[1]. It predominantly localizes to the cytoplasm and plasma membrane of premeiotic testicular germ cells, and experimental evidence implicates a role in germ cell maturation and progression of certain testicular tumors[3]. Disorders associated with PRSS21 include testicular cancer and inflammatory bowel disease 12[3]. No drugs are currently documented to target PRSS21 directly. Its canonical enzymatic activity and localization suggest it may serve as a marker or future therapeutic target related to testis biology and select cancers[3][4].
Serine-type endopeptidase activity (inhibition or modulation of enzymatic activity could underlie pharmacological strategies)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine protease 21 (PRSS21).